$177 Million is the total value of JNE Partners LLP's 13 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
UHAL | AMERCO | $32,835,000 | +9.6% | 50,826 | 0.0% | 18.52% | -15.8% | |
CMCSA | COMCAST CORP NEWcl a | $31,427,000 | -1.9% | 561,902 | 0.0% | 17.72% | -24.6% | |
MSDAU | MSD ACQUISITION CORPunit 03/25/2026 | $15,015,000 | -0.9% | 1,500,000 | 0.0% | 8.47% | -23.9% | |
ORIAU | ORION BIOTECH OPPORTUNTES COunit 04/15/2025 | $14,851,000 | -1.5% | 1,500,000 | 0.0% | 8.37% | -24.3% | |
NG | NOVAGOLD RES INC | $13,451,000 | -14.1% | 1,955,047 | 0.0% | 7.58% | -34.0% | |
EOCWU | ELLIOTT OPPORTUNITY II CORPunit 99/99/9999 | $11,132,000 | +1.1% | 1,100,000 | 0.0% | 6.28% | -22.3% | |
WALD | WALDENCAST ACQUISITION CORP | $9,800,000 | -1.5% | 1,000,000 | 0.0% | 5.53% | -24.3% | |
RKTAU | ROCKET INTERNET GRWT OPRT COunit 99/99/9999 | $4,294,000 | -0.3% | 430,234 | 0.0% | 2.42% | -23.4% | |
KAHCU | KKR ACQUISITION HOLDING I COunit 99/99/9999 | $2,294,000 | -0.6% | 229,866 | 0.0% | 1.29% | -23.6% | |
WALDW | WALDENCAST ACQUISITION CORP*w exp 03/11/202 | $287,000 | -21.8% | 333,333 | 0.0% | 0.16% | -39.8% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
NOVAGOLD RES INC | 16 | Q3 2023 | 34.9% |
AMERCO | 11 | Q3 2022 | 40.0% |
ELLIOTT OPPORTUNITY II CORP | 9 | Q2 2023 | 19.8% |
COMCAST CORP NEW | 8 | Q1 2022 | 23.5% |
ORION BIOTECH OPPORTUNTES CO | 8 | Q1 2023 | 11.1% |
MSD ACQUISITION CORP | 8 | Q4 2022 | 11.1% |
LIBERTY MEDIA CORP DEL | 8 | Q2 2023 | 13.9% |
ROCKET INTERNET GRWT OPRT CO | 8 | Q4 2022 | 3.2% |
KKR ACQUISITION HOLDING I CO | 7 | Q3 2022 | 1.7% |
MICRON TECHNOLOGY INC | 5 | Q3 2023 | 56.9% |
View JNE Partners LLP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Prevail Therapeutics Inc. | January 29, 2021 | ? | ? |
View JNE Partners LLP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-15 |
13F-HR | 2021-11-15 |
View JNE Partners LLP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.